Similar Search Results

The Spatial Mismatch between Innovation and Joblessness

Glaeser, Edward L. - 2019

's most persistent pockets of joblessness. Could a more even spatial distribution of innovation reduce American joblessness …? Could Federal policies disperse innovation without significant costs? If research funding is already maximizing knowledge … production, then spatial reallocation of that funding will reduce America's overall innovation unless that reallocation comes …

Persistent link: https://www.econbiz.de/10012869066

The Impact of New Drug Launches on Longevity : Evidence from Longitudinal Disease-Level Data from 52 Countries, 1982-2001

Lichtenberg, Frank R. - 2021

We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to...

Persistent link: https://www.econbiz.de/10013245298

The rise of the skilled city

Glaeser, Edward L.; Saiz, Albert - 2003

Persistent link: https://www.econbiz.de/10002455820

Measuring Gentrification : Using Yelp Data to Quantify Neighborhood Change

Glaeser, Edward L. - 2018

We demonstrate that data from digital platforms such as Yelp have the potential to improve our understanding of gentrification, both by providing data in close to real time (i.e. nowcasting and forecasting) and by providing additional context about how the local economy is changing. Combining...

Persistent link: https://www.econbiz.de/10012911707

Corruption in America

Glaeser, Edward L.; Saks, Raven E. - 2021

We use a data set of federal corruption convictions in the U.S. to investigate the causes and consequences of corruption. More educated states, and to a less degree richer states, have less corruption. This relationship holds even when we use historical factors like education in 1928 or...

Persistent link: https://www.econbiz.de/10013218129

The Allocation of Publicly-Funded Biomedical Research

Lichtenberg, Frank R. - 2021

We develop a simple theoretical model of the allocation of public biomedical research expenditure, and present some empirical evidence about the determinants of this allocation. The structure of expenditure should depend on the relative costs as well as the relative benefits of different kinds...

Persistent link: https://www.econbiz.de/10013219295

Cities, Regions and the Decline of Transport Costs

Glaeser, Edward L.; Kohlhase, Janet E. - 2021

The theoretical framework of urban and regional economics is built on transportation costs for manufactured goods. But over the twentieth century, the costs of moving these goods have declined by over 90% in real terms, and there is little reason to doubt that this decline will continue....

Persistent link: https://www.econbiz.de/10013220511

International R&D Spillovers : A Re-Examination

Lichtenberg, Frank R.; van Pottelsberghe de la … - 2021

Coe and Helpman(1995) have measured the extent to which technology spills over between industrialized countries through the particular channel of trade flows. This paper re-examines two particular features of their study. First, we suggest that their functional form of how foreign R&D affects...

Persistent link: https://www.econbiz.de/10013221859

The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output

Lichtenberg, Frank R. - 2021

We hypothesize that pharmaceutical-embodied technical progress increases per capita output via its effect on labor supply (the employment rate and hours worked per employed person). We examine the effect of changes in both the average quantity and average vintage (FDA approval year) of drugs...

Persistent link: https://www.econbiz.de/10013222635

Sources of U.S. Longevity Increase, 1960-1997

Lichtenberg, Frank R. - 2021

models using annual U.S. time-series data on life expectancy, health expenditure, and medical innovation. Reliable annual … data are available for only one type of innovation - new drugs - but pharmaceutical R&D accounts for a significant fraction … innovation (in the form of new drug approvals) and expenditure on medical care (especially public expenditure) contributed to …

Persistent link: https://www.econbiz.de/10013224922